← Retour à la une
États-Unis · Plateformes & données · Yahoo Finance

Mammogen Launches Leadership Council to Unite Industry Experts and Survivors, Names Former Quest Diagnostics CMO Dr. Yuri Fesko as Founding Member

Publié par Yahoo Finance · États-Unis il y a 8 h
Mammogen, Inc.
Mammogen, Inc. · Yahoo Finance

Résumé détaillé

New council will help shape clinical adoption, strategic partnerships and patient access as Mammogen advances its genTRU-breast™ diagnostic through prospective clinical validation…

New council will help shape clinical adoption, strategic partnerships and patient access as Mammogen advances its genTRU-breast™ diagnostic through prospective clinical validation

NEWPORT BEACH, Calif., Nov. 17, 2026 (GLOBE NEWSWIRE) -- Mammogen, a molecular diagnostics company validating blood-based RNA technology for breast cancer detection, today announced the formation of its Leadership Council and the appointment of Yuri Fesko, M.D., former Chief Medical Officer of Quest Diagnostics and current Chief Medical Officer of Quanterix, as its founding member.

Established as Mammogen advances its genTRU-breast™ diagnostic technology through prospective clinical validation, the Leadership Council is designed to accelerate scientific innovation into real-world patient impact. Moving beyond the traditional scientific advisory board model, the Council will unite leaders across clinical medicine, diagnostics, healthcare delivery and commercial strategy with breast cancer survivors to help shape the company's approach to clinical adoption, strategic partnerships and patient access.

"We are bringing together the people who understand what it actually takes to change how breast cancer is detected," said Elizabeth Cormier-May, CEO of Mammogen. "Breakthrough science alone does not change healthcare. It takes clinical conviction, commercial execution, healthcare system adoption and the voices of the women whose lives depend on getting it right. Our Leadership Council is designed to connect those forces from the outset. This is how we intend to move from innovation to meaningful impact."

Founding member Dr. Fesko brings extensive experience spanning clinical oncology, precision medicine, laboratory diagnostics and healthcare leadership. He currently serves as Chief Medical Officer of Quanterix, a company advancing ultra-sensitive biomarker detection technologies, and previously served as Chief Medical Officer of Quest Diagnostics, one of the nation's largest diagnostic testing…

During…

Début de l'article, extrait de Yahoo Finance. Pour lire la suite, ouvrez l'article chez le média.

Lire l'article complet sur Yahoo Finance Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (finance.yahoo.com)

À lire aussi